Comment on the NICE Technology Appraisal Guidance on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for treatment of non-small lung cancer

NHS Quality Improvement Scotland
Record ID 32002000055
English
Details
Project Status: Completed
Year Published: 2001
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Scotland, United Kingdom
MeSH Terms
  • Carcinoma, Non-Small-Cell Lung
  • Docetaxel
  • Paclitaxel
  • Vinorelbine
  • Drug Therapy
  • Practice Guidelines as Topic
  • Antineoplastic Combined Chemotherapy Protocols
  • Deoxycytidine
  • Lung Neoplasms
  • Taxoids
  • Vinblastine
Contact
Organisation Name: Health Technology Board for Scotland
Contact Address: Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name: shtg.hcis@nhs.net
Contact Email: shtg.hcis@nhs.net
Copyright: Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS))
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.